Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep799 | Late Breaking | ECE2021

Comparison of patients with normocalcemic and hypercalcemic primary hyperparathyroidism

leyla akdoğan , Burcak Polat Sefika , Aydin Cevdet , Ogmen Berna , Topaloglu Oya , Ersoy Reyhan , Cakir Bekir

ObjectivePrimary hyperparathyroidism (PHPT) is the most common cause of hypercalcemia. A group of patients who were followed up with a diagnosis of PHPT had normal calcium levels with high parathyroid hormone (PTH) levels. For the diagnosis of normocalcemic PHPT, secondary causes of hyperparathyroidism such as vitamin D deficiency should be excluded. In this study, the data of 318 PHPT patients who were operated were retrospectively analyzed, and biochem...

ea0070aep235 | Bone and Calcium | ECE2020

The transition range and acceleration from normocalcemia to hypercalcemia in patients with primary hyperparathyroidism: Does it provide a new perspective?

Akdoğan Leyla , Aydin Cevdet , Bașer Hüsniye , Çuhacı Seyrek Neslihan , Ersoy Reyhan , Cakir Bekir

Objective: Primary hyperparathyroidism (PHPT) is a clinical condition characterized by hypercalcemia-specific symptoms and signs caused by excessive secretion of parathormone. After the evaluation of blood calcium measurements within routine tests, the frequency of hyperparathyroidism increased and there is a marked decrease in the frequency of classical symptoms and signs. Recently, most PHPT cases are detected in the asymptomatic period, and which of these asymptomatic patie...

ea0073aep884 | Late Breaking | ECE2021

A tru-cut biopsy proven rare thyroid neoplasia in a giant nodule with a benign fine needle aspiration cytology

Leyla Akdoğan , Ahmadova Konul , Bestepe Nagihan , Burcak Polat Sefika , Dilek Imdat , Aydin Cevdet , Topaloglu Oya , Ersoy Reyhan , Cakir Bekir

IntroductionExtramedullary plasmacytoma (EMP) is a plasma cell neoplasm of extraosseous tissues. Less than 5% of all plasma cell neoplasms develop extramedullary. EMP is most common in the upper respiratory tract and oral cavity. The thyroid gland is one of the extremely rare regions. It is more common in men and the average age at diagnosis is 55. Primary thyroid plasmacytoma is one of the rare thyroid neoplasms. It often manifests as a rapidly growing ...

ea0073ep239 | Late Breaking | ECE2021

A rare cause of levothyroxine malabsorption: İleostomy

Leyla Akdoğan , Ahmadova Konul , Sacikara Muhammed , Ali Tam Abbas , Ozdemir Didem , Topaloglu Oya , Ersoy Reyhan , Cakir Bekir

IntroductionIt is recommended to determine levothyroxine (LT4) dose individually in patients with hypothyroidism. However, higher doses of LT4 therapy are required to achieve target TSH levels in significant number of patients. Oral LT4 absorption occurs in the small intestine, especially in the jejunum and proximal ileum, while a small amount is absorbed in duodenum. Causes of LT4 malabsorption include helicobacter pylori infection, chronic atrophic gas...

ea0070ep350 | Pituitary and Neuroendocrinology | ECE2020

Case report: the combination of acromegaly, primary hyperparathyroidism and colon cancer

Akdoğan Leyla , Serdar Deniz Muzaffer , Saçikara Muhammed , Nasiroğlu Narin , Ali Tam Abbas , Çuhaci Seyrek Neslihan

Introduction: Acromegaly is a chronic disease caused by excess growth hormone (GH) release from an adenoma caused by somatotroph cells of pituitary gland.In acromegaly, it is known that the risk of thyroid and colon cancer is increased 8 and 4 times, respectively, compared to the normal population.Moderate hypercalcemia, due to vitaminD activation, is seen in acromegaly, but overt hypercalcemia, generally secondary to primary hyperparathyroidism, is rare.Combination of acromeg...

ea0073aep886 | Late Breaking | ECE2021

Hematological changes before and after radioactive iodine therapy

leyla akdoğan , Burcak Polat Sefika , Fatma Neslihan Cuhaci Seyrek , Ali Tam Abbas , Ozdemir Elif , Aydin Cevdet , Topaloglu Oya , Ersoy Reyhan , Cakir Bekir

ObjectiveRadioactive iodine (RAI) therapy is widely used in both diagnosis and treatment of benign and malignant thyroid diseases. It is generally a well tolerated therapy. Bone marrow suppression is often a temporary side effect with a decrease in white blood cells and platelets up to 6–10 weeks. In this study, we aimed to examine hematological changes in patients who received RAI treatment for benign or malignant diseases of the thyroid.<p cla...